SV Atlas
← All founders
2018Co-founder· 64x Bio
Founder · since 2018
Company
64x Bio
Role
Co-founder & CEO
current
Stage
—
no public source
Raised
—
no public source
Based
San Francisco Bay Area
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
64x Bio logo
64x Bio

Enabling next generation medicines. A comprehensive platform and…

Summer 2018

Experience

Career

  • 64x Bio logo

    64x Bio

    Co-founder

    Co-founder & CEO · San Francisco Bay Area · 2018 – Present

    2018
  • Wyss Institute for Biologically Inspired Engineering logo

    Wyss Institute for Biologically Inspired Engineering

    Postdoctoral Research Fellow · Boston, MA · 2016 – 2018

    2016
  • Harvard Medical School logo

    Harvard Medical School

    Postdoctoral Research Fellow · Boston, MA · 2015 – 2018

    2015
  • Yale University logo

    Yale University

    Graduate Student · New Haven, CT · 2010 – 2015

    2010
  • University of California, Berkeley logo

    University of California, Berkeley

    Research Assistant · Berkeley, CA · 2008 – 2010

    2008
  • University of California, San Francisco logo

    University of California, San Francisco

    Undergraduate Research Assistant · San Francisco, CA · 2007

    2007

Bio

Lexi Rovner, PhD is the CEO & co-founder of 64x Bio, a spinout of Harvard Medical School and the Wyss Institute. Lexi completed her PhD at Yale University and her postdoctoral work in George Church’s lab at Harvard Medical School, where she co-founded the company alongside George, Pam Silver, Jeff Way, and David Thompson. Lexi is a Y Combinator alum, a 2022 Endpoints 20 under 40 Next-Generation Biotech Leader, and a 2022 Bloomberg New Economy Catalyst Awardee.